<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829487</url>
  </required_header>
  <id_info>
    <org_study_id>247/2021</org_study_id>
    <nct_id>NCT04829487</nct_id>
  </id_info>
  <brief_title>The Role of Vitamin D Supplementation on Pain in Women With Primary Dysmenorrhea and Hypovitaminosis D</brief_title>
  <official_title>The Role of Vitamin D Supplementation on Pain in Women With Primary Dysmenorrhea and Hypovitaminosis D: A Randomized, Double-blind, Placebo-Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of vitamin D supplementation on the pain&#xD;
      score of primary dysmenorrhea. Our hypothesis is that by normalizing vitamin D level could&#xD;
      help improve pain score of women who have primary dysmenorrhea.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is aimed to be conducted in randomised controlled trial, comparing between&#xD;
      intervention group and placebo group. We include women with primary dysmenorrhea who also&#xD;
      have low vitamin D level in this trial. Our primary outcome is to compare visual analog pain&#xD;
      scale between intervention and placebo group after treatment. After randomised and allocated,&#xD;
      these women will be given vitamin D 50,000 IU or placebo capsules orally weekly for 8&#xD;
      consecutive weeks. We monitor pain score daily from the cycle before the drugs started until&#xD;
      complete 8-week course of the regimen mentioned. Also vitamin D levels will be monitored&#xD;
      twice, one before treatment and the other after treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised controlled study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog pain scale</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pain score between intervention and placebo group after treatment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Hypovitaminosis D</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D 50,000 IU orally weekly for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsules orally weekly for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ergocalciferol Capsules</intervention_name>
    <description>Given to subjects 50,000 IU per week for 8 weeks</description>
    <arm_group_label>Vitamin D</arm_group_label>
    <other_name>Vitamin D2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo capsules</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary dysmenorrhea&#xD;
&#xD;
          -  Hypovitaminosis D&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Using calcium, magnesium or phosphorus in the past 3 months&#xD;
&#xD;
          -  Using hormonal contraception or IUD in the past 6 months&#xD;
&#xD;
          -  No smoking or alcohol drinking&#xD;
&#xD;
          -  Chronic underlying diseases&#xD;
&#xD;
          -  Allergic to components in study drugs&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mananya Silpakit, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Reproductive medicine unit, Department of OB-GYN, Faculty of Medicine, Siriraj Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mananya Silpakit, Doctor</last_name>
    <phone>+66987795945</phone>
    <email>msilpakit@gmail.com</email>
  </overall_contact>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 31, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Preeyaporn Jirakittidul</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rickets</mesh_term>
    <mesh_term>Avitaminosis</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Dysmenorrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

